Evaluation Of The Use Of Cyclophosphamide In Children Diagnosed With Steroid Resistant Nephrotic Syndrome Treated In The 3rd Floor Treatment At Fatmawati Hospital
##plugins.themes.academic_pro.article.sidebar##
##plugins.themes.academic_pro.article.main##
Abstract
A total of 32 children with nephrotic syndrome were treated with cyclophosphamide, the remissions and side effects that often occurred during therapy were counted. This research was conducted using a retrospective descriptive method. The results showed that the remission was 59.4%. The mean duration of the call to remission was 14 weeks and the mean dose of cyclophosphamide was 589 mg. As many as 59.4% of patients experienced no side effects, while 40.6% experienced side effects. Side effects that occurred included vomiting (3.1%); nausea (3.1%); hair loss (6.3%); nausea and vomiting (12.5%); vomiting and hair loss (6.3%); nausea and hair loss (6.3%); and nausea, vomiting, and hair loss (3.1%).
Keywords: Steroid-Resistant Nephrotic Syndrome, Cyclophosphamide
##plugins.themes.academic_pro.article.details##
References
2. Lia Ariani, eprints.ums.ac.id
3. Travis L. Nephrotic syndrome. Emed Journal. 2012; 3(3):154-6
4. Trihono, P.P., Alatas, H.,Tambunan, T., Pardede, S.O., 2012. Tata laksana sindrom nefrotik idiopatik pada anak. Edisi ke-2, Badan Penerbit Ikatan Dokter Anak Indonesia.
5. Leliana, V., Muryawan, M.H., Radityo A.N., 2012. Association between corticosteroid therapy and cataract in children with nephrotic syndrome. J. Media Medika Muda.
6. Radde, I.C., Macleod, S.M., 1999. Farmakologi & terapi pediatri. Edisi ke-2, Jakarta; EGC, hal 380-419.
7. Burgess, D.N., Bakris G.L., 2001. Kelainan ginjal dan elektrolit. Dalam: S. Komala, A.H. Santoso, Ilmu penyakit dalam, Jakarta: Buku Kedokteran EGC.